Nichols & Pratt Advisers LLP Abbott Laboratories Transaction History
Nichols & Pratt Advisers LLP
- $1.45 Billion
- Q2 2024
A detailed history of Nichols & Pratt Advisers LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 36,562 shares of ABT stock, worth $3.83 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
36,562
Previous 36,862
0.81%
Holding current value
$3.83 Million
Previous $4.19 Million
9.31%
% of portfolio
0.26%
Previous 0.29%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,111Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.19M-
Vanguard Group Inc Valley Forge, PA165MShares$17.3 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.9 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.8 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.83 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.35 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $183B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...